Effect of glutamine supplementation on cardiovascular risk factors in patients with type 2 diabetes.

[1]  B. Larijani,et al.  Nutrients related to GLP1 secretory responses. , 2013, Nutrition.

[2]  H. Randeva,et al.  Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis , 2013, BMJ Open.

[3]  E. L. Rosado,et al.  ω-3 polyunsaturated fatty acid supplementation does not influence body composition, insulin resistance, and lipemia in women with type 2 diabetes and obesity. , 2012, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[4]  W. Chiu,et al.  Effects of dietary glutamine on inflammatory mediator gene expressions in rats with streptozotocin-induced diabetes. , 2012, Nutrition.

[5]  M. Sampson,et al.  Chronic Ingestion of Flavan-3-ols and Isoflavones Improves Insulin Sensitivity and Lipoprotein Status and Attenuates Estimated 10-Year CVD Risk in Medicated Postmenopausal Women With Type 2 Diabetes , 2012, Diabetes Care.

[6]  J. Holst,et al.  Regulation of glucagon secretion by incretins , 2011, Diabetes, obesity & metabolism.

[7]  C. Lewis,et al.  Association Between Insulin Resistance and Lean Mass Loss and Fat Mass Gain in Older Men without Diabetes Mellitus , 2011, Journal of the American Geriatrics Society.

[8]  J. Holst,et al.  Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients. , 2011, The Journal of nutrition.

[9]  T. Wadden,et al.  Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes , 2011, Diabetes Care.

[10]  F. Hartgens,et al.  Prolonged leucine supplementation does not augment muscle mass or affect glycemic control in elderly type 2 diabetic men. , 2011, The Journal of nutrition.

[11]  J. Tong,et al.  Is the GLP-1 system a viable therapeutic target for weight reduction? , 2011, Reviews in Endocrine and Metabolic Disorders.

[12]  W. Chiu,et al.  Effects of dietary glutamine on adhesion molecule expression and oxidative stress in mice with streptozotocin-induced type 1 diabetes. , 2011, Clinical nutrition.

[13]  A. Goebel-Fabbri,et al.  Nutrition Therapy and the Management of Obesity and Diabetes: An Update , 2011, Current diabetes reports.

[14]  V. Basevi.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[15]  J. Woo,et al.  The effect of diabetes mellitus on age‐associated lean mass loss in 3153 older adults , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[16]  E. Noreen,et al.  Effects of supplemental fish oil on resting metabolic rate, body composition, and salivary cortisol in healthy adults , 2010, Journal of the International Society of Sports Nutrition.

[17]  H. J. Yoo,et al.  Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes , 2010, Diabetes Care.

[18]  M. Teixeira,et al.  The safety of oral use of L-glutamine in middle-aged and elderly individuals. , 2010, Nutrition.

[19]  C. Perlemoine,et al.  Insulin Therapy and Body Weight, Body Composition and Muscular Strength in Patients with Type 2 Diabetes Mellitus , 2009, Journal of nutrition and metabolism.

[20]  Jiang He,et al.  Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes , 2009, Annals of Internal Medicine.

[21]  J. Hsu,et al.  Comparison of dietary conjugated linoleic acid with safflower oil on body composition in obese postmenopausal women with type 2 diabetes mellitus. , 2009, The American journal of clinical nutrition.

[22]  L. Kuller,et al.  Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes , 2009, Diabetes Care.

[23]  J. Wernerman.  Clinical use of glutamine supplementation. , 2008, The Journal of nutrition.

[24]  C. Gazzaruso,et al.  Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia. , 2008, The American journal of cardiology.

[25]  M. Blaha,et al.  Waist Circumference, Not the Metabolic Syndrome, Predicts Glucose Deterioration in Type 2 Diabetes , 2008, Obesity.

[26]  C. Dejong,et al.  Specific amino acids in the critically ill patient—Exogenous glutamine/arginine: A common denominator? , 2007, Critical care medicine.

[27]  J. Carvalheira,et al.  RETRACTED ARTICLE:l-glutamine supplementation induces insulin resistance in adipose tissue and improves insulin signalling in liver and muscle of rats with diet-induced obesity , 2007, Diabetologia.

[28]  Andy Coward,et al.  Estimating under-reporting of energy intake in dietary surveys using an individualised method , 2007, British Journal of Nutrition.

[29]  Myriam Nenquin,et al.  Nutrient Control of Insulin Secretion in Isolated Normal Human Islets , 2006, Diabetes.

[30]  Jacqueline Capeau,et al.  Recent advances in the relationship between obesity, inflammation, and insulin resistance. , 2006, European cytokine network.

[31]  Paul Poirier,et al.  Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism , 2006, Circulation.

[32]  J. Pachl,et al.  Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients , 2006, Critical care medicine.

[33]  C. Dejong,et al.  Intestinal renal metabolism of L-citrulline and L-arginine following enteral or parenteral infusion of L-alanyl-L-[2,15N]glutamine or L-[2,15N]glutamine in mice. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[34]  K. Naseem.  The role of nitric oxide in cardiovascular diseases. , 2005, Molecular aspects of medicine.

[35]  M. Elia,et al.  Bioelectrical impedance analysis--part I: review of principles and methods. , 2004, Clinical nutrition.

[36]  G. Rutter,et al.  Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells , 2004, Diabetologia.

[37]  Y. Boirie,et al.  A weight reduction program preserves fat-free mass but not metabolic rate in obese adolescents. , 2004, Obesity research.

[38]  P. Wischmeyer,et al.  Prevention of chemotherapy and radiation toxicity with glutamine. , 2003, Cancer treatment reviews.

[39]  B. Ainsworth,et al.  International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.

[40]  J. Holst,et al.  The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects. , 2003, Diabetes.

[41]  W. Jagust,et al.  Prevalence of Dementia in Older Latinos: The Influence of Type 2 Diabetes Mellitus, Stroke and Genetic Factors , 2003, Journal of the American Geriatrics Society.

[42]  R. Prentice,et al.  Participant characteristics associated with errors in self-reported energy intake from the Women's Health Initiative food-frequency questionnaire. , 2002, The American journal of clinical nutrition.

[43]  G. Slama,et al.  Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men. , 2002, Diabetes care.

[44]  D. Wilmore,et al.  The effect of glutamine supplementation in patients following elective surgery and accidental injury. , 2001, The Journal of nutrition.

[45]  R. Hill,et al.  The validity of self-reported energy intake as determined using the doubly labelled water technique , 2001, British Journal of Nutrition.

[46]  A. Wagenmakers,et al.  Response of glutamine metabolism to glutamine-supplemented parenteral nutrition. , 2000, The American journal of clinical nutrition.

[47]  D A Follmann,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .

[48]  M. Holeček,et al.  Effect of alanyl-glutamine on leucine and protein metabolism in endotoxemic rats. , 2000, JPEN. Journal of parenteral and enteral nutrition.

[49]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[50]  J. Holst,et al.  Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. , 2009, The American journal of clinical nutrition.

[51]  J. Vuichoud,et al.  Effect of glutamine supplementation of the diet on tissue protein synthesis rate of glucocorticoid-treated rats. , 2001, Nutrition.

[52]  M. Feinglos,et al.  L-glutamine supplementation of a high fat diet reduces body weight and attenuates hyperglycemia and hyperinsulinemia in C57BL/6J mice. , 1996, The Journal of nutrition.